![](/img/cover-not-exists.png)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos, Ludwig, Bar-Or, Amit, Cree, Bruce A C, Fox, Robert J, Giovannoni, Gavin, Gold, Ralf, Vermersch, Patrick, Arnold, Douglas L, Arnould, Sophie, Scherz, Tatiana, Wolf, Christian, Wallström, Erik,Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(18)30475-6
Date:
March, 2018
File:
PDF, 1.01 MB
english, 2018